Richmond Pharmacology is excited to join the PNS Congress 2026 in Maastricht, The Netherlands, on 12- 15 June 2026.

Bringing together global leaders in peripheral nerve research and clinical care, this meeting serves as a key platform for advancing understanding of neuromuscular disorders, accelerating therapeutic innovation, and fostering collaboration between academia, industry, and patient organizations.

Representing Richmond Pharmacology

Dr Jörg Taubel, Chief Executive Officer

We look forward to connecting with attendees to discuss Richmond’s expertise in:

  • Advances in peripheral nerve disorder research and treatment
  • Translational approaches for early-phase drug development
  • Regulatory considerations for innovative therapies
  • Patient-centric trial design and recruitment strategies
  • Strengthening partnerships across academia, industry, and advocacy groups

Connect With Us

If you are attending the PNS Annual Meeting 2026 and would like to explore partnership or development opportunities email us at:

📧 fasteranswers@richmondpharmacology.com

Latest news

Richmond Pharmacology Appoints Dr Daniel Chapple as Commercial Director

July 13, 2026
Richmond Pharmacology, the London-based contract research organisation and global leader in early phase clinical trials, announces the appointment of Dr Daniel Chapple PhD FCIM as Commercial Director.
Read more

Upcoming Event

ESC Congress 2026

28 - 31 August 2026
Richmond Pharmacology is pleased to attend the ESC Congress 2026 in Munich, Germany, on 28 - 31 August 2026.
View event